INTRODUCTION

MATERIALS AND METHODS
Study population
Device selection and Solumbra technique
![]() | Fig. 1.Solumbra technique thrombectomy with a Solitaire platinum 4×40 mm stent retriever. A : Initial angiography revealed left M1 occlusion. B : A non-subtracted image showed a deployed Solitaire platinum 4×40 mm stent retriever (black arrow : the proximal end of the working device; black dotted arrow : the distal end of the working device) and a 6 French Catalyst (CAT6) aspiration catheter (white arrow : distal tip of the aspiration catheter). C : Using a weak pull of the Solitaire platinum 4×40 mm stent retriever, the distal tip of the CAT6 aspiration catheter is moved to the proximal end of the working length of the stent retriever. To contact the thrombus, the distal tip of the CAT6 should be placed just proximal to the thrombus (black arrow : the proximal end of the working length of the stent; white arrow : distal tip of the aspiration catheter). D : After retrieval of the Solitaire platinum 4×40 mm and CAT6 with simultaneous aspiration, angiography revealed the complete reperfusion status of the left M1. |
Multivariable factors and outcome and complications
Statistical analyses

RESULTS
Baseline characteristics and procedure detail
Table 1.
Variable | 4×40 (25 patients) | 4×20 (45 patients) | p-value* |
---|---|---|---|
Dermographic | |||
Sex, male | 14 (56.0) | 27 (60.0) | 0.601 |
Age (years) | 72.0±12.7 | 69.0±13.1 | 0.449 |
HTN | 15 (60.0) | 25 (55.6) | 0.552 |
DM | 5 (20.0) | 10 (22.2) | 0.680 |
Af | 8 (32.0) | 12 (26.7) | 0.346 |
CAD | 5 (20.0) | 9 (20.0) | 0.889 |
Dyslipidemia | 7 (28.0) | 16 (35.6) | 0.465 |
Smoking | 5 (20.0) | 13 (28.9) | 0.263 |
Prior stroke or TIA | 4 (16.0) | 7 (15.6) | 0.793 |
Previous anti-platelet use | 6 (24.0) | 9 (20.0) | 0.571 |
Previous anti-coagulant use | 3 (12.0) | 4 (8.9) | 0.466 |
Occlusions in the left hemisphere | 14 (56.0) | 24 (53.3) | 0.702 |
IV t-PA | 8 (32.0) | 18 (40.0) | 0.109 |
Initial NIHSS | 10 (2–18) | 8 (2–18) | 0.127 |
ASPECTS score | 9 (6–10) | 9 (6–10) | 0.924 |
Etiology of stroke | |||
Cardio-embolic | 10 (40.0) | 22 (48.9) | 0.297 |
Atherosclerosis | 7 (28.0) | 10 (22.2) | 0.382 |
Dissection | 1 (4.0) | 1 (2.2) | 0.307 |
Other or undetermined | 7 (28.0) | 12 (26.7) | 0.693 |
Site of arterial occlusion | |||
MCA | 13 (52.0) | 27 (60.0) | 0.419 |
Distal ICA | 10 (40.0) | 13 (28.9) | 0.310 |
Posterior circulation | 2 (8.0) | 5 (11.1) | 0.507 |
Procedure detail | |||
Procedure time (minutes) | 34 (14–82) | 46 (15–91) | 0.247 |
Use of BGC | 24 (96.0) | 42 (93.3) | 0.776 |
Aspirationcatheter,CAT6:Sofia5 | 21 : 4 | 33 : 12 | 0.186 |
Radiopaque stent retriever | 25 (100.0) | 20 (44.4) | 0.001† |
* p-values are calculated by chi-square test or Fisher’s exact test and Mann-Whitney U test or Student’s t-test.
4×40 : Solitaire Platinum 4×40 mm stent retriever, 4×20 : Solitaire 2 FR 4×20 mm stent retriever + Solitaire Platinum 4×20 mm stent retriever, HTN : hypertension, DM : diabetes mellitus, Af : atrial fibrillation, CAD : coronary artery disease, TIA : transient ischemic attack, IV t-PA : intravenous tissue-plasminogen activator, NIHSS : National Institutes of Health Stroke Scale, ASPECT : Alberta Stroke Program Early CT, MCA : middle cerebral artery, ICA : internal carotid artery, BGC : balloon guide catheter, CAT6 : 6 Fr Catalyst, Sofia5 : 5 Fr Sofia
Outcomes and complications
Table 2.
4×40 (25 patients) | 4×20 (25 patients) | p-value* | |
---|---|---|---|
Outcome | |||
Successful recanalization | 24 (96.0) | 43 (95.6) | 0.842 |
First-pass reperfusion | 17 (68.0) | 21 (46.7) | 0.004† |
First-pass complete reperfusion | 12 (48.0) | 15 (33.3) | 0.007† |
Favorable 3 months mRS | 14 (56.0) | 23 (51.1) | 0.592 |
Complication | |||
Post thrombectomy hemorrhage | 2 (8.0) | 4 (8.9) | 0.627 |
Symptomatic hemorrhage | 1 (4.0) | 2 (4.4) | 0.793 |
Vessel perforation | 0 (0.0) | 0 (0.0) | 1.000 |
Arterial dissection | 0 (0.0) | 0 (0.0) | 1.000 |
Distal emboli | 2 (8.0) | 4 (8.9) | 0.679 |
Hemorrhagic transformation of infarct | 4 (16.0) | 9 (20.0) | 0.391 |
3 months mortality | 2 (8.0) | 4 (8.9) | 0.497 |
* p-values are calculated by chi-square test or Fisher’s exact test and Mann-Whitney U test or Student’s t-test.
4×40 : Solitaire Platinum 4×40 mm stent retriever, 4×20 : Solitaire 2 FR 4×20 mm stent retriever + Solitaire Platinum 4×20 mm stent retriever, Successful recanalization : thrombolysis in cerebral infarction 2b or 3, mRS : modified Rankin Scale, Favorable mRS : 90 days mRS ≤2, First-pass reperfusion : modified thrombolysis in cerebral infarction 2b or 3 with the first pass, First-pass complete reperfusion : modified thrombolysis in cerebral infarction 3 with the first pass
Predictors of reperfusion and full reperfusion with first pass
Table 3.
OR | 95% CI | p-value* | |
---|---|---|---|
First-pass reperfusion | |||
Initial NIHSS | 2.95 | 0.61–4.38 | 0.442 |
IV t-PA | 0.97 | 0.58–2.26 | 0.367 |
CAT6 Aspiration catheter | 1.86 | 0.78–3.14 | 0.172 |
Radiopaque stent retriever | 2.08 | 1.22–3.84 | 0.014† |
Long stent retriever (Platinum 4×40 mm) | 2.81 | 1.34–4.10 | 0.008† |
First-pass complete reperfusion | |||
Initial NIHSS | 2.72 | 0.58–4.46 | 0.407 |
IV t-PA | 0.82 | 0.66–3.08 | 0.266 |
CAT6 Aspiration catheter | 2.06 | 0.82–3.90 | 0.312 |
Radiopaque stent retriever | 1.88 | 1.20–3.12 | 0.022† |
Long stent retriever (Platinum 4×40 mm) | 2.12 | 1.48–3.76 | 0.012† |
TICI : thrombolysis in cerebral infarction, OR : odds ratio, CI : confidence interval, First-pass reperfusion : modified TICI 2b or 3 with the first pass, NIHSS : National Institutes of Health Stroke Scale, IV t-PA : intravenous tissue-plasminogen activator, CAT6 : 6 French Catalyst, First-pass complete reperfusion : modified TICI 3 with the first pass

DISCUSSION
![]() | Fig. 2.Representative case of solumbra technique thrombectomy with a Solitaire platinum 4×40 mm stent retriever. A : Roadmap image shows the location of the devices, before their retrieval (black arrow : the proximal end of the working length of the stent; black dotted arrow : mid-portion marker of the stent; white arrow : distal tip of the aspiration catheter). B : By a weak pull of the Solitaire platinum 4×40 mm stent retriever, the distal tip of aspiration catheter (white arrow) should be placed just proximal to the thrombus and between the two markers (black and black dotted arrows) of the Solitaire platinum 4×40 mm stent. C : After retrieval of the Solumbra technique devices, the thrombus was captured by the aspiration catheter and stent retriever. D : Image of the solumbra technique system after retrieval, in which the tip of the aspiration catheter was located distally beyond the midportion marker of the stent retriever. |

CONCLUSION
